@article{Saleem_Ishaq_Shafique_Fawad_Fatima_2016, title={INTRAVITREAL TRIAMCINOLONE ALONE VERSUS COMBINED INTRAVITREAL TRIAMCINOLONE AND BEVACIZUMAB ON CENTRAL MACULAR THICKNESS IN DIABETIC MACULAR EDEMA: Triamcinolone Versus Bevacizumab on Central Macular Thickness}, volume={66}, url={https://pafmj.org/PAFMJ/article/view/1283}, abstractNote={<p><strong>Objective:</strong> To compare the effect of intravitreal triamcinolone (IVT) alone with combined intravitreal triamcinolone (IVT) and intravitreal bevacizumab (IVB) on central macular thickness (CMT) in patients of diabetic macular edema (DME).<br><strong>Study Design:</strong> Randomized control trial.<br><strong>Place and Duration of Study: </strong>Armed Forces Institute of Ophthalmology, Jun 2013 to Dec 2013.<br><strong>Material and Methods:</strong> Eighty patients were included in the study through non probability consecutive sampling and were randomized to IVT alone or IVT + IVB group using random number table. Pre and post injection (12 weeks) CMT were recorded and intra and inter group comparison was performed.<br><strong>Results: </strong>Both groups showed statistically significant reduction in mean CMT at 12 weeks (p<0.05). In Group A, mean CMT reduction at 12 weeks was 64.33 microns (SD=15.17) while in Group B it was 75.18 (SD=20.82). On comparison, IVT + IVB group was more effective in reducing CMT with statistically significant difference (p=0.009).<br><strong>Conclusion:</strong> Intravitreal triamcinolone used in combination with IVB is more effective in reducing central macular thickness in diabetic macular edema (DME) than intravitreal triamcinolone alone.</p> <p> </p>}, number={6}, journal={Pakistan Armed Forces Medical Journal}, author={Saleem, Beenish and Ishaq, Mazhar and Shafique, Maeirah and Fawad, Aisha and Fatima, Samar}, year={2016}, month={Dec.}, pages={913–17} }